Bausch Health Companies Inc. Increase (Decrease) in Inventories
Bausch Health Companies Inc. (BHC) reported Increase (Decrease) in Inventories of $36.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-30
- Bausch Health Companies Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $22.00M.
- Bausch Health Companies Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $14.00M, a 53.33% decline year-over-year.
- Bausch Health Companies Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $5.00M, a 89.80% decline year-over-year.
- Bausch Health Companies Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$16.00M, a 138.10% decline year-over-year.
- Bausch Health Companies Inc. increase (decrease) in inventories for fiscal 2025 was $12.00M, a 95.51% decline from fiscal 2024.
- Bausch Health Companies Inc. increase (decrease) in inventories for fiscal 2024 was $267.00M, a 17.08% decline from fiscal 2023.
- Bausch Health Companies Inc. increase (decrease) in inventories for fiscal 2023 was $322.00M, a 62.63% increase from fiscal 2022.
- Bausch Health Companies Inc. increase (decrease) in inventories for fiscal 2022 was $198.00M, a 1137.50% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $22.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $36.00M 10-Q · filed 2026-07-30 | $41.00M derived: sum of 3 quarters · filed 2026-07-30 | $25.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $14.00M 10-Q · filed 2026-04-30 | $19.00M derived: sum of 2 quarters · filed 2026-04-30 | $3.00M derived: sum of 3 quarters · filed 2026-04-30 | -$4.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$11.00M derived: sum of 2 quarters · filed 2026-02-19 | -$18.00M derived: sum of 3 quarters · filed 2026-07-30 | $12.00M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | -$16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$23.00M derived: sum of 2 quarters · filed 2026-07-30 | $7.00M 10-Q · filed 2025-10-30 | $56.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $23.00M 10-Q · filed 2026-07-30 | $72.00M derived: sum of 3 quarters · filed 2026-07-30 | $114.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $30.00M 10-Q · filed 2026-04-30 | $79.00M derived: sum of 2 quarters · filed 2026-04-30 | $121.00M derived: sum of 3 quarters · filed 2026-04-30 | $153.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $91.00M derived: sum of 2 quarters · filed 2026-02-19 | $123.00M derived: sum of 3 quarters · filed 2026-02-19 | $267.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $42.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $74.00M derived: sum of 2 quarters · filed 2025-10-30 | $218.00M 10-Q · filed 2025-10-30 | $318.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $32.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $176.00M 10-Q · filed 2025-07-31 | $276.00M derived: sum of 3 quarters · filed 2026-02-19 | $338.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $144.00M 10-Q · filed 2025-05-01 | $244.00M derived: sum of 2 quarters · filed 2026-02-19 | $306.00M derived: sum of 3 quarters · filed 2026-02-19 | $338.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $162.00M derived: sum of 2 quarters · filed 2026-02-19 | $194.00M derived: sum of 3 quarters · filed 2026-02-19 | $322.00M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $62.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $94.00M derived: sum of 2 quarters · filed 2024-10-31 | $222.00M 10-Q · filed 2024-10-31 | $226.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $32.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $160.00M 10-Q · filed 2024-08-01 | $164.00M derived: sum of 3 quarters · filed 2025-02-20 | $220.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $128.00M 10-Q · filed 2024-05-02 | $132.00M derived: sum of 2 quarters · filed 2025-02-20 | $188.00M derived: sum of 3 quarters · filed 2025-02-20 | $253.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $60.00M derived: sum of 2 quarters · filed 2025-02-20 | $125.00M derived: sum of 3 quarters · filed 2025-02-20 | $198.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $56.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $121.00M derived: sum of 2 quarters · filed 2023-11-02 | $194.00M 10-Q · filed 2023-11-02 | $148.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $65.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $138.00M 10-Q · filed 2023-08-03 | $92.00M derived: sum of 3 quarters · filed 2024-02-22 | $107.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $73.00M 10-Q · filed 2023-05-04 | $27.00M derived: sum of 2 quarters · filed 2024-02-22 | $42.00M derived: sum of 3 quarters · filed 2024-02-22 | $54.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | -$46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$31.00M derived: sum of 2 quarters · filed 2024-02-22 | -$19.00M derived: sum of 3 quarters · filed 2024-02-22 | $16.00M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $27.00M derived: sum of 2 quarters · filed 2022-11-03 | $62.00M 10-Q · filed 2022-11-03 | -$39.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $47.00M 10-Q · filed 2022-08-09 | -$54.00M derived: sum of 3 quarters · filed 2023-02-23 | -$64.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $35.00M 10-Q · filed 2022-05-10 | -$66.00M derived: sum of 2 quarters · filed 2023-02-23 | -$76.00M derived: sum of 3 quarters · filed 2023-02-23 | $18.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$101.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$111.00M derived: sum of 2 quarters · filed 2023-02-23 | -$17.00M derived: sum of 3 quarters · filed 2023-02-23 | $77.00M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $84.00M derived: sum of 2 quarters · filed 2021-11-02 | $178.00M 10-Q · filed 2021-11-02 | $182.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $94.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $188.00M 10-Q · filed 2021-08-03 | $192.00M derived: sum of 3 quarters · filed 2022-05-11 | $276.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | $94.00M 10-Q · filed 2021-05-04 | $98.00M derived: sum of 2 quarters · filed 2022-05-11 | $182.00M derived: sum of 3 quarters · filed 2022-05-11 | $235.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $4.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $88.00M derived: sum of 2 quarters · filed 2022-05-11 | $141.00M derived: sum of 3 quarters · filed 2022-05-11 | $209.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $84.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $137.00M derived: sum of 2 quarters · filed 2020-11-03 | $205.00M 10-Q · filed 2020-11-03 | $202.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $53.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $121.00M 10-Q · filed 2020-08-06 | $118.00M derived: sum of 3 quarters · filed 2021-05-04 | $114.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $68.00M 10-Q · filed 2020-05-07 | $65.00M derived: sum of 2 quarters · filed 2021-05-04 | $61.00M derived: sum of 3 quarters · filed 2021-05-04 | $73.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | -$3.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | -$7.00M derived: sum of 2 quarters · filed 2021-05-04 | $5.00M derived: sum of 3 quarters · filed 2021-05-04 | $5.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $8.00M derived: sum of 2 quarters · filed 2019-11-04 | $8.00M 10-Q · filed 2019-11-04 | $2.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $12.00M 10-Q · filed 2019-08-06 | $6.00M derived: sum of 3 quarters · filed 2020-02-19 | $5.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-06 | -$6.00M derived: sum of 2 quarters · filed 2020-02-19 | -$7.00M derived: sum of 3 quarters · filed 2020-02-19 | -$45.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$7.00M derived: sum of 2 quarters · filed 2020-02-19 | -$45.00M derived: sum of 3 quarters · filed 2020-02-19 | -$7.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$39.00M derived: sum of 2 quarters · filed 2018-11-06 | -$1.00M 10-Q · filed 2018-11-06 | -$3.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | -$38.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | -$2.00M derived: sum of 3 quarters · filed 2019-02-20 | $19.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $38.00M 10-Q · filed 2018-05-08 | $36.00M derived: sum of 2 quarters · filed 2019-02-20 | $57.00M derived: sum of 3 quarters · filed 2019-02-20 | $116.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $19.00M derived: sum of 2 quarters · filed 2019-02-20 | $78.00M derived: sum of 3 quarters · filed 2019-02-20 | $164.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $80.00M derived: sum of 2 quarters · filed 2017-11-07 | $166.00M 10-Q · filed 2017-11-07 | $166.30M 10-Q · filed 2016-11-09 | $257.10M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $59.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $145.00M 10-Q · filed 2017-08-08 | $145.10M 10-Q · filed 2016-08-09 | $236.10M derived: sum of 3 quarters · filed 2018-08-10 | $281.70M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $86.00M 10-Q · filed 2017-05-09 | $85.90M 10-Q · filed 2016-06-07 | $177.10M derived: sum of 2 quarters · filed 2018-08-10 | $222.70M derived: sum of 3 quarters · filed 2018-08-10 | $271.00M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $91.10M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $136.70M derived: sum of 2 quarters · filed 2018-08-10 | $185.00M derived: sum of 3 quarters · filed 2018-08-10 | $276.00M 8-K · filed 2018-08-10 | ||||
| 2015-09-30 | $45.60M 10-Q · filed 2015-10-26 | $93.90M derived: sum of 2 quarters · filed 2015-10-26 | $184.90M 10-Q · filed 2016-11-09 | $132.40M 10-Q · filed 2015-10-26 | $255.10M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $48.30M 10-Q · filed 2015-07-28 | $139.30M 10-Q · filed 2016-08-09 | $86.80M 10-Q · filed 2015-07-28 | $209.50M derived: sum of 3 quarters · filed 2017-03-01 | $251.00M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $91.00M 10-Q · filed 2016-06-07 | $38.50M 10-Q · filed 2015-04-30 | $161.20M derived: sum of 2 quarters · filed 2017-03-01 | $202.70M derived: sum of 3 quarters · filed 2017-03-01 | $214.80M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $70.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $111.70M derived: sum of 2 quarters · filed 2017-03-01 | $123.80M derived: sum of 3 quarters · filed 2017-03-01 | $193.00M 10-K · filed 2017-03-01 | $174.30M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $41.50M 10-Q · filed 2015-10-26 | $53.60M derived: sum of 2 quarters · filed 2015-10-26 | $122.80M 10-Q · filed 2015-10-26 | $140.40M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $12.10M 10-Q · filed 2015-07-28 | $81.30M 10-Q · filed 2015-07-28 | $98.90M derived: sum of 3 quarters · filed 2016-04-29 | $145.10M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $69.20M 10-Q · filed 2015-04-30 | $86.80M derived: sum of 2 quarters · filed 2016-04-29 | $133.00M derived: sum of 3 quarters · filed 2016-04-29 | $167.00M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $17.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $63.80M derived: sum of 2 quarters · filed 2016-04-29 | $97.80M derived: sum of 3 quarters · filed 2016-04-29 | $122.70M 10-K · filed 2016-04-29 | $122.70M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $46.20M 10-Q · filed 2014-10-24 | $46.15M 10-Q · filed 2013-11-01 | $80.20M derived: sum of 2 quarters · filed 2014-10-24 | $105.10M 10-Q · filed 2014-10-24 | $105.06M 10-Q · filed 2013-11-01 | $124.10M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $34.00M 10-Q · filed 2014-08-01 | $33.96M 10-Q · filed 2013-08-07 | $58.90M 10-Q · filed 2014-08-01 | $58.91M 10-Q · filed 2013-08-07 | $77.90M derived: sum of 3 quarters · filed 2015-02-25 | $87.69M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $24.90M 10-Q · filed 2014-05-09 | $24.95M 10-Q · filed 2013-05-03 | $43.90M derived: sum of 2 quarters · filed 2015-02-25 | $53.69M derived: sum of 3 quarters · filed 2015-02-25 | $70.12M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $28.79M derived: sum of 2 quarters · filed 2015-02-25 | $45.22M derived: sum of 3 quarters · filed 2015-02-25 | $80.30M 10-K · filed 2015-02-25 | $80.30M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $9.79M 10-Q · filed 2013-11-01 | $26.22M derived: sum of 2 quarters · filed 2013-11-01 | $61.30M 10-Q · filed 2013-11-01 | $72.75M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $16.43M 10-Q · filed 2013-08-07 | $51.51M 10-Q · filed 2013-08-07 | $62.97M derived: sum of 3 quarters · filed 2014-02-28 | $68.18M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $35.08M 10-Q · filed 2013-05-03 | $46.53M derived: sum of 2 quarters · filed 2014-02-28 | $51.74M derived: sum of 3 quarters · filed 2014-02-28 | $59.96M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $11.45M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $16.66M derived: sum of 2 quarters · filed 2014-02-28 | $24.88M derived: sum of 3 quarters · filed 2014-02-28 | $11.52M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $5.21M 10-Q · filed 2012-11-05 | $13.43M derived: sum of 2 quarters · filed 2012-11-05 | $68.00K 10-Q · filed 2012-11-05 | -$10.85M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $8.22M 10-Q · filed 2012-08-03 | -$5.14M 10-Q · filed 2012-08-03 | -$16.06M derived: sum of 3 quarters · filed 2013-02-28 | -$18.42M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | -$13.36M 10-Q · filed 2012-05-04 | -$24.27M derived: sum of 2 quarters · filed 2013-02-28 | -$26.63M derived: sum of 3 quarters · filed 2013-02-28 | -$31.95M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | -$10.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$13.27M derived: sum of 2 quarters · filed 2013-02-28 | -$18.59M derived: sum of 3 quarters · filed 2013-02-28 | -$7.46M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | -$2.36M 10-Q · filed 2011-11-04 | -$1.75M 10-Q · filed 2010-11-05 | -$7.67M derived: sum of 2 quarters · filed 2011-11-04 | $3.45M 10-Q · filed 2011-11-04 | $4.07M 10-Q · filed 2010-11-05 | $25.91M derived: sum of 4 quarters · filed 2012-02-29 | ||
| 2010-06-30 | -$5.31M 10-Q · filed 2011-08-08 | -$9.04M 10-Q · filed 2010-08-06 | $5.81M 10-Q · filed 2011-08-08 | $5.82M 10-Q · filed 2010-08-06 | $28.27M derived: sum of 3 quarters · filed 2012-02-29 | $30.66M derived: sum of 4 quarters · filed 2012-02-29 | ||
| 2010-03-31 | $11.12M 10-Q · filed 2011-05-10 | $33.58M derived: sum of 2 quarters · filed 2012-02-29 | $35.97M derived: sum of 3 quarters · filed 2012-02-29 | $45.93M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $22.46M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $24.85M derived: sum of 2 quarters · filed 2012-02-29 | $34.81M derived: sum of 3 quarters · filed 2012-02-29 | $33.58M 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $2.39M 10-Q · filed 2010-11-05 | $12.35M derived: sum of 2 quarters · filed 2010-11-05 | $11.13M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $9.96M 10-Q · filed 2010-08-06 | $8.73M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | -$16.29M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |